🇺🇸 FDA
Patent

US 11731978

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

granted A61KA61K45/06A61P

Quick answer

US patent 11731978 (3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator) held by PRAXIS PRECISION MEDICINES, INC. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS PRECISION MEDICINES, INC.
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K45/06, A61P, A61P23/00, A61P25/08